Baird Initiates Coverage of Omada Health (OMDA) with Neutral Recommendation

Omada Health, Inc.

Baird Initiates Coverage of Omada Health (OMDA) with Neutral Recommendation

2025-09-05 12:03
US

Fintel reports that on September 5, 2025, Baird initiated coverage of Omada Health (NasdaqGS:OMDA) with a Neutral recommendation.

Analyst Price Forecast Suggests 19.18% Upside

As of September 4, 2025, the average one-year price target for Omada Health is $28.27/share. The forecasts range from a low of $24.24 to a high of $32.55. The average price target represents an increase of 19.18% from its latest reported closing price of $23.72 / share.

See our leaderboard of companies with the largest price target upside.

The projected annual non-GAAP EPS is -0.58.

What are Other Shareholders Doing?

OMDA / Omada Health, Inc. Shares Held by Institutions

AH Capital Management, L.L.C. holds 4,615K shares representing 8.01% ownership of the company.

NVP Associates holds 2,531K shares representing 4.40% ownership of the company.

Perceptive Advisors holds 2,426K shares representing 4.21% ownership of the company.

Loomis Sayles & Co L P holds 1,090K shares representing 1.89% ownership of the company.

Rock Springs Capital Management holds 920K shares representing 1.60% ownership of the company.

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista